Skip to main content

Table 5 Multivariate analysis of the inflammation-based cumulative prognostic score (ICPS) and IPI score

From: An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era

Characteristic

OS

PFS

P-value

HR (95% Cl)

P-value

HR (95% Cl)

IPI (Hi, H)

<0.001

2.697 (1.652–4.405)

0.001

1.892(1.293–1.767)

ICPS ≥ 2

<0.001

3.044 (1.929–4.804)

<0.001

2.293(1.577–3.335)

  1. Abbreviations: OS Overall survival, PFS Progression-free survival, HR Hazard Ratio, 95% Cl, 95% confidence limits, IPI International Prognostic Index, Hi High-intermediate, H High, ICPS Inflammation-based cumulative prognostic score
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us